ERYTECH’s shareholders are hereby informed of the Annual General Meeting which will be held on June 23, 2023 at 09:30am CEST at the Hôtel Intercontinental, 2 rue Scribe, 75009 Paris…
Erytech provided a business and financial update for the fourth quarter and full year of 2022.
ERYTECH and PHERECYDES announced their proposed strategic combination intended to create a global player in extended phage therapy and accelerate the development of a portfolio of drug candidates targeting pathogenic…
Conference call and webcast on Tuesday, November 22, 2022 at 8:30am EST / 02:30pm CEST
Erytech announced that it received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC regarding its American Depositary Shares ("ADSs")
ERYTECH Pharma today provided a business and financial update for the first half of 2022.